Stoke Therapeutics, Inc. (STOK)
32.49
-0.79
(-2.37%)
USD |
NASDAQ |
May 07, 11:46
Stoke Therapeutics Free Cash Flow : 44.92M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.316B |
| Krystal Biotech, Inc. | 237.38M |
| Scholar Rock Holding Corp. | -300.64M |
| Vertex Pharmaceuticals, Inc. | 3.710B |
| Zymeworks, Inc. | -35.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.45M |
| Cash from Investing (Quarterly) | -61.06M |
| Cash from Financing (Quarterly) | 92.34M |
| Free Cash Flow Per Share (Quarterly) | -0.5255 |
| Free Cash Flow to Equity (Quarterly) | -30.05M |
| Free Cash Flow to Firm (Quarterly) | -30.68M |
| Free Cash Flow Yield | 2.36% |